KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,150,000 | -60.4% | 225,000 | -47.1% | 1.13% | -51.5% |
Q3 2021 | $7,960,000 | -45.5% | 425,000 | -39.3% | 2.33% | -42.0% |
Q2 2021 | $14,595,000 | -14.0% | 700,000 | +16.7% | 4.01% | +0.6% |
Q1 2021 | $16,962,000 | +59.8% | 600,000 | +84.6% | 3.99% | +68.6% |
Q4 2020 | $10,615,000 | +54.0% | 325,000 | +44.4% | 2.36% | +18.7% |
Q3 2020 | $6,894,000 | +71.3% | 225,000 | -2.2% | 1.99% | +132.8% |
Q3 2018 | $4,025,000 | -3.8% | 230,000 | 0.0% | 0.86% | -30.5% |
Q2 2018 | $4,186,000 | – | 230,000 | – | 1.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |